Yield10 Bioscience, Inc. (YTEN)

NASDAQ: YTEN · IEX Real-Time Price · USD
2.78
0.41 (17.30%)
At close: May 16, 2022 4:00 PM
2.85
0.07 (2.52%)
After-hours:May 16, 2022 7:51 PM EDT
Market Cap13.63M
Revenue (ttm)567,000
Net Income (ttm)-11.80M
Shares Out4.90M
EPS (ttm)-2.33
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume514,408
Open2.40
Previous Close2.37
Day's Range2.40 - 2.85
52-Week Range1.91 - 10.10
Beta1.33
AnalystsBuy
Price Target13.01 (+368.0%)
Earnings DateMay 11, 2022

About YTEN

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. T...

IndustryBiotechnology
IPO DateNov 10, 2006
CEOOliver Peoples
Employees29
Stock ExchangeNASDAQ
Ticker SymbolYTEN
Full Company Profile

Financial Performance

In 2021, YTEN's revenue was $614,000, a decrease of -23.15% compared to the previous year's $799,000. Losses were -$11.03 million, 8.08% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for YTEN stock is "Buy." The 12-month stock price forecast is 13.01, which is an increase of 367.99% from the latest price.

Price Target
$13.01
(367.99% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Metabolix, Inc. (YTEN) Reports Q1 Loss, Misses Revenue Estimates

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -3.03% and 10.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

5 days ago - Zacks Investment Research

Yield10 Bioscience Announces First Quarter 2022 Financial Results

-Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update

5 days ago - GlobeNewsWire

Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, ...

WOBURN, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its ...

1 week ago - GlobeNewsWire

Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill Executive, as Special Commercial and Technical Advisor

WOBURN, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today named Willie Loh, Ph.D., as a special adv...

2 weeks ago - GlobeNewsWire

Should You Buy Wheat Stocks? 3 Companies To Consider.

Surging wheat prices could provide systemic support to many commodity stocks that have U.S. exposure. Here are three wheat stocks to buy.

Other symbols:ANDEBG
1 month ago - InvestorPlace

Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat

WOBURN, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver P...

1 month ago - GlobeNewsWire

Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in B...

-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels

2 months ago - GlobeNewsWire

Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results

-Near-term commercial focus on the Renewable Diesel market

2 months ago - GlobeNewsWire

Yield10 Bioscience Announces an Update on the Camelina Line E3902 Development Program for Producing Low-carbon Feedst...

Company is Scaling up Camelina Line E3902 Seed Production  and Developing Herbicide Tolerant Lines

2 months ago - GlobeNewsWire

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wedn...

WOBURN, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report it...

2 months ago - GlobeNewsWire

Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola

Increasing Oil Content in Oilseed Crops is Required to Meet the Projected Demand for Renewable Diesel Increasing Oil Content in Oilseed Crops is Required to Meet the Projected Demand for Renewable Diesel

2 months ago - GlobeNewsWire

Yield10 Bioscience Receives Favorable Ruling from the Argentine Biosafety Commission (CONABIA) for Company's Camelina...

Three Yield10 CRISPR Genome-Edited Camelina Lines Were Determined to be Similar to Conventional Camelina Varieties and Not Subject to Regulation Three Yield10 CRISPR Genome-Edited Camelina Lines Were De...

3 months ago - GlobeNewsWire

Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations

WOBURN, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the hiring of Darren Greenfield to serve as the Company's Sen...

3 months ago - GlobeNewsWire

Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference

WOBURN, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a cor...

4 months ago - GlobeNewsWire

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing t...

WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present ...

5 months ago - GlobeNewsWire

Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of 22.22% and -57.99%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Yield10 Bioscience Announces Third Quarter 2021 Financial Results

Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results and Provide a Corporate Update Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financi...

6 months ago - GlobeNewsWire

Will Metabolix, Inc. (YTEN) Report Negative Q3 Earnings? What You Should Know

Metabolix, Inc. (YTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

Yield10 Bioscience to Announce Third Quarter 2021 Financial Results and Host a Conference Call on Wednesday, November...

WOBURN, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its third quarter 2021 financial...

6 months ago - GlobeNewsWire

Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference

WOBURN, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will present at ...

7 months ago - GlobeNewsWire

Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a co...

8 months ago - GlobeNewsWire

Metabolix, Inc. (YTEN) Reports Q2 Loss, Lags Revenue Estimates

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -20.75% and -17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Yield10 Bioscience Announces Second Quarter 2021 Financial Results

Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review

9 months ago - GlobeNewsWire

Will Metabolix, Inc. (YTEN) Report Negative Q2 Earnings? What You Should Know

Metabolix, Inc. (YTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research